SCHEMBL6635985

SCHEMBL6635985

Cn1c(CNc2ccc(C#N)cc2)nc2cc(N(C3CCCC3)S(C)(=O)=O)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 7/20 0.43
CHEK2 O96017 3/20 0.43
PRKCG P05129 3/20 0.43
CSNK1D P48730 3/20 0.43
RPS6KA3 P51812 3/20 0.43
DYRK1A Q13627 3/20 0.43
AURKB Q96GD4 3/20 0.43
IRAK4 Q9NWZ3 3/20 0.43
MAP4K4 O95819 2/20 0.43
PHKG2 P15735 2/20 0.43
MARK3 P27448 2/20 0.43
CSNK1A1 P48729 2/20 0.43
CLK2 P49760 2/20 0.43
IRAK1 P51617 2/20 0.43
NEK4 P51957 2/20 0.43
CSNK1G2 P78368 2/20 0.43
MAP4K2 Q12851 2/20 0.43
PRKAA1 Q13131 2/20 0.43
CAMK2G Q13555 2/20 0.43
PKN2 Q16513 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8029894 0.87 ITK (0.43) ITKCHEK2PRKCGCSNK1DRPS6KA3
SCHEMBL8027050 0.86 ITK (0.45) ITKCHEK2PRKCGCSNK1DRPS6KA3
SCHEMBL8109532 0.84 F2 (0.55) HDAC6F2
SCHEMBL6635652 0.84 PPARG (0.43) ITKCHEK2PRKCGCSNK1DRPS6KA3
SCHEMBL6635980 0.79 SMN1; SMN2 (0.42) HDAC6F2NPC1RAB9ASMN1; SMN2
SCHEMBL6635650 0.77 ITK (0.45) ITKCHEK2PRKCGCSNK1DRPS6KA3
SCHEMBL14914339 0.76 HDAC6 (0.51) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL19339630 0.75 HDAC6 (0.48) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL6780857 0.74 NQO2 (0.56) ITKHDAC6F2NPC1RAB9A
SCHEMBL6637018 0.73 NPC1 (0.48) HDAC6F2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed